NIH Weekly Funding Opportunities & Notices

Published Saturday, February 17, 2018

Requests for Applications

  • Towards Implementing Novel Training Methods to Enhance Cognition in Aging (U01 Clinical Trial Required)
    (RFA-AG-18-031)
    National Institute on Aging
    Application Receipt Date(s): April 30, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. 
  • SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Focused Technologies Toward Commercialization (R44 Clinical Trial Optional)
    (RFA-CA-18-011)
    National Cancer Institute
    Application Receipt Date(s): August 15, 2018, by 5:00 PM local time of applicant organization. 
  • Exploiting Omics Assays to Investigate Molecular Regulation of Persistent HIV in Individuals with Substance Use Disorder (R61/R33 Clinical Trial Optional)
    (RFA-DA-19-003)
    National Institute on Drug Abuse
    Application Receipt Date(s): Not Applicable 
  • Limited Competition: FaceBase 3: Craniofacial Development and Dysmorphology Data Management and Integration Hub (U01 Clinical Trial Not Allowed)
    (RFA-DE-19-003)
    National Institute of Dental and Craniofacial Research
    Application Receipt Date(s): July 17, 2018 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Late applications will not be accepted in response to this FOA. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 
  • Mass Spectrometric Assays for the Reliable and Reproducible Detection of Proteins/Peptides of Importance in Type 1 Diabetes Research (U01 Clinical Trial Not Allowed)
    (RFA-DK-17-019)
    National Institute of Diabetes and Digestive and Kidney Diseases
    Application Receipt Date(s): July 10, 2018), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. 
  • Immune System Engineering For Targeted Tolerance in Type 1 Diabetes (R01 Clinical Trial Not Allowed)
    (RFA-DK-17-020)
    National Institute of Diabetes and Digestive and Kidney Diseases
    National Institute of Allergy and Infectious Diseases
    Application Receipt Date(s): May 10, 2018 and December 6, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. 
  • Discovery of Early Type 1 Diabetes Disease Biomarkers in the Human Pancreas [HIRN Consortium on Beta Cell Death and Survival (CBDS)] (U01 - Clinical Trial Not Allowed)
    (RFA-DK-17-021)
    National Institute of Diabetes and Digestive and Kidney Diseases
    Application Receipt Date(s): May 10, 2018 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will not be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 
  • High-Resolution Exploration of the Human Islet Tissue Environment [HIRN Human Pancreas Analysis Consortium (HPAC)] (U01 Clinical Trial Not Allowed)
    (RFA-DK-17-022)
    National Institute of Diabetes and Digestive and Kidney Diseases
    Application Receipt Date(s): May 10, 2018 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. 
  • Clinical, Behavioral and Physiological Research Testing Current and Novel Closed Loop Systems (R01- Clinical Trial Required)
    (RFA-DK-17-023)
    National Institute of Diabetes and Digestive and Kidney Diseases
    Application Receipt Date(s): April 26, 2018 and December 6, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. 
  • Impact of the Use of Glucose Monitoring and Control Technologies on Health Outcomes and Quality of Life in Older Adults with Type 1 Diabetes (T1D) (R01 Clinical Trial Required)
    (RFA-DK-17-024)
    National Institute of Diabetes and Digestive and Kidney Diseases
    Application Receipt Date(s): April 26, 2018 and Dec 6, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. 
  • Development and Integration of Novel Components for Open and Closed Loop Hormone Replacement Platforms for T1D Therapy (R01- Clinical Trial Optional)
    (RFA-DK-17-025)
    National Institute of Diabetes and Digestive and Kidney Diseases
    Application Receipt Date(s): May 10, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. 
  • Career Development Programs in Diabetes Research for Endocrinologists (K12 Clinical Trial Optional)
    (RFA-DK-17-026)
    National Institute of Diabetes and Digestive and Kidney Diseases
    Application Receipt Date(s): April 26, 2018 and December 6, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 
  • Incorporating Patient-Reported Outcomes into Clinical Care for Type 1 Diabetes (R01 Clinical Trial Required)
    (RFA-DK-17-027)
    National Institute of Diabetes and Digestive and Kidney Diseases
    Application Receipt Date(s): July 10, 2018 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 
  • Treating Diabetes Distress to Improve Glycemic Outcomes in Type 1 Diabetes (R01 Clinical Trial Required)
    (RFA-DK-17-028)
    National Institute of Diabetes and Digestive and Kidney Diseases
    Application Receipt Date(s): July 10, 2018 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcements. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date 
  • The Characterization and Discovery of Novel Autoantigens and Epitopes in Type 1 Diabetes (R01 Clinical Trial Optional)
    (RFA-DK-17-031)
    National Institute of Diabetes and Digestive and Kidney Diseases
    Application Receipt Date(s): April 26, 2018 and December 6, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications are allowed for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 
  • Funding For Collaborative Clinical Research In Type 1 Diabetes: Living Biobank (R01 Clinical Trial Optional)
    (RFA-DK-17-032)
    National Institute of Diabetes and Digestive and Kidney Diseases
    Application Receipt Date(s): July 10, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 
  • Elucidating the Effect of Glycemic Excursions on Patient Well-being and Cognitive Status in People with Type 1 Diabetes (T1D) (R01 Clinical Trial Optional)
    (RFA-DK-18-003)
    National Institute of Diabetes and Digestive and Kidney Diseases
    Application Receipt Date(s): July 10, 2018), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 
  • Development of New Technologies and Bioengineering Solutions for the Advancement of Cell Replacement Therapies for Type 1 Diabetes (T1D) (R01 Clinical Trial Optional)
    (RFA-DK-18-004)
    National Institute of Diabetes and Digestive and Kidney Diseases
    Application Receipt Date(s): May 10, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. 
  • National Laboratory Curriculum Framework Development
    (RFA-FD-18-005)
    Food and Drug Administration
    Application Receipt Date(s): April 20,2018, by 11:59 PM Eastern Time. 
  • Male and Female Contraceptive Development (R43/R44 Clinical Trial Optional)
    (RFA-HD-19-004)
    Eunice Kennedy ShriverNational Institute of Child Health and Human Development 
    Application Receipt Date(s): April 16, 2018, by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 
  • National Research Mentoring Network (NRMN) Resource Center (U24 - Clinical Trial Not Allowed)
    (RFA-RM-18-002)
    Office of Strategic Coordination (Common Fund)
    Office of Strategic Coordination (Common Fund)
    Application Receipt Date(s): June 11, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. 
  • National Research Mentoring Network (NRMN) Coordination Center (U24 - Clinical Trial Not Allowed)
    (RFA-RM-18-003)
    Office of Strategic Coordination (Common Fund)
    Office of Strategic Coordination (Common Fund)
    Application Receipt Date(s): June 11, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. 
  • National Research Mentoring Network: The Science of Mentoring, Networking, and Navigating Career Transition Points (U01 Clinical Trial Not Allowed)
    (RFA-RM-18-004)
    Office of Strategic Coordination (Common Fund)
    Office of Strategic Coordination (Common Fund)
    Application Receipt Date(s): June 11, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. 

Program Announcements

  • Developmentally Tailored HIV Prevention and Care Research for Adolescents and Young Adults (R01 Clinical Trial Optional)
    (PA-18-651)
    National Institute of Mental Health
    National Institute of Allergy and Infectious Diseases
    National Institute on Drug Abuse
    National Institute on Minority Health and Health Disparities 
    Application Receipt/Submission Date(s): Standard AIDS dates apply, by 5:00 PM local time of applicant organization. All types of AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 
  • Developmentally Tailored HIV Prevention and Care Research for Adolescents and Young Adults (R21 Clinical Trial Not Allowed)
    (PA-18-652)
    National Institute of Mental Health
    National Institute of Allergy and Infectious Diseases
    National Institute on Drug Abuse
    Application Receipt/Submission Date(s): Standard AIDS dates apply, by 5:00 PM local time of applicant organization. All types of AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 
  • Developmentally Tailored HIV Prevention and Care Research for Adolescents and Young Adults (R34 Clinical Trial Optional)
    (PA-18-653)
    National Institute of Mental Health
    National Institute on Drug Abuse
    Application Receipt/Submission Date(s): Standard AIDS dates apply, by 5:00 PM local time of applicant organization. All types of AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 
  • Administrative Supplement for Research on Sex/Gender Influences (Admin Supp - Clinical Trial Optional)
    (PA-18-658)
    Office of Research on Women's Health
    John E. Fogarty International Center
    National Center for Advancing Translational Sciences
    National Center for Complementary and Integrative Health
    National Cancer Institute
    National Eye Institute
    National Human Genome Research Institute
    National Heart, Lung, and Blood Institute
    National Institute on Aging
    National Institute on Alcohol Abuse and Alcoholism
    National Institute of Allergy and Infectious Diseases
    National Institute of Arthritis and Musculoskeletal and Skin Diseases
    National Institute of Biomedical Imaging and Bioengineering
    Eunice Kennedy Shriver National Institute of Child Health and Human Development 
    National Institute on Drug Abuse
    National Institute on Deafness and Other Communication Disorders
    National Institute of Dental and Craniofacial Research
    National Institute of Diabetes and Digestive and Kidney Diseases
    National Institute of Environmental Health Sciences
    National Institute of General Medical Sciences
    National Institute of Mental Health
    National Institute on Minority Health and Health Disparities 
    National Institute of Neurological Disorders and Stroke
    National Institute of Nursing Research
    National Library of Medicine
    Office of the Director, NIH
    Application Receipt/Submission Date(s): March 26, 2018, by 5:00 PM local time of applicant organization.
  • Genetics of Alcohol Sensitivity and Tolerance (R01 Clinical Trial Not Allowed)
    (PA-18-660)
    National Institute on Alcohol Abuse and Alcoholism
    Application Receipt/Submission Date(s): Standard dates apply), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. 
  • Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (Parent F31)
    (PA-18-666)
    National Institutes of Health
    National Center for Complementary and Integrative Health
    National Cancer Institute
    National Eye Institute
    National Human Genome Research Institute
    National Institute on Aging
    National Institute on Alcohol Abuse and Alcoholism
    National Institute of Allergy and Infectious Diseases
    National Institute of Arthritis and Musculoskeletal and Skin Diseases
    Eunice Kennedy Shriver National Institute of Child Health and Human Development 
    National Institute on Drug Abuse
    National Institute on Deafness and Other Communication Disorders
    National Institute of Dental and Craniofacial Research
    National Institute of Diabetes and Digestive and Kidney Diseases
    National Institute of Environmental Health Sciences
    National Institute of General Medical Sciences
    National Institute of Mental Health
    National Institute on Minority Health and Health Disparities 
    National Institute of Neurological Disorders and Stroke
    National Institute of Nursing Research
    National Library of Medicine
    Office of the Director, NIH
    Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. 
  • Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions with NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30)
    (PA-18-668)
    National Institutes of Health
    National Center for Complementary and Integrative Health
    National Cancer Institute
    National Eye Institute
    National Human Genome Research Institute
    National Institute on Aging
    National Institute on Alcohol Abuse and Alcoholism
    National Institute of Allergy and Infectious Diseases
    Eunice Kennedy Shriver National Institute of Child Health and Human Development 
    National Institute on Drug Abuse
    National Institute on Deafness and Other Communication Disorders
    National Institute of Dental and Craniofacial Research
    National Institute of Diabetes and Digestive and Kidney Diseases
    National Institute of Environmental Health Sciences
    National Institute of Mental Health
    National Institute on Minority Health and Health Disparities 
    Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. 
  • Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32)
    (PA-18-670)
    National Institutes of Health
    National Center for Complementary and Integrative Health
    National Cancer Institute
    National Eye Institute
    National Human Genome Research Institute
    National Institute on Aging
    National Institute on Alcohol Abuse and Alcoholism
    National Institute of Allergy and Infectious Diseases
    National Institute of Arthritis and Musculoskeletal and Skin Diseases
    National Institute of Biomedical Imaging and Bioengineering
    Eunice Kennedy Shriver National Institute of Child Health and Human Development 
    National Institute on Drug Abuse
    National Institute on Deafness and Other Communication Disorders
    National Institute of Dental and Craniofacial Research
    National Institute of Diabetes and Digestive and Kidney Diseases
    National Institute of Environmental Health Sciences
    National Institute of General Medical Sciences
    National Institute of Mental Health
    National Institute on Minority Health and Health Disparities 
    National Institute of Nursing Research
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. 
  • Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31)
    (PA-18-671)
    National Institutes of Health
    National Center for Complementary and Integrative Health
    National Cancer Institute
    National Eye Institute
    National Human Genome Research Institute
    National Institute on Aging
    National Institute on Alcohol Abuse and Alcoholism
    National Institute of Allergy and Infectious Diseases
    National Institute of Arthritis and Musculoskeletal and Skin Diseases
    Eunice Kennedy Shriver National Institute of Child Health and Human Development 
    National Institute on Drug Abuse
    National Institute on Deafness and Other Communication Disorders
    National Institute of Dental and Craniofacial Research
    National Institute of Diabetes and Digestive and Kidney Diseases
    National Institute of Environmental Health Sciences
    National Institute of Mental Health
    National Institute on Minority Health and Health Disparities 
    National Institute of Neurological Disorders and Stroke
    National Institute of Nursing Research
    National Library of Medicine
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. 
  • Basic Research in Cancer Health Disparities (R01 Clinical Trials Not Allowed)
    (PAR-18-654)
    National Cancer Institute
    National Institute on Minority Health and Health Disparities 
    Application Receipt/Submission Date(s): June 19, 2018; November 19, 2018; June 18, 2019; November 19, 2019; June 18, 2020; November 19, 2020, by 5:00 PM local time of applicant organization, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. 
  • Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)
    (PAR-18-655)
    National Cancer Institute
    National Institute on Minority Health and Health Disparities 
    Application Receipt/Submission Date(s): June 19 2018; November 19, 2018; June 18, 2019; November 19, 2019; June 18, 2020; November 19, 2020, by 5:00 PM local time of applicant organization, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. 
  • NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
    (PAR-18-656)
    National Institute of Dental and Craniofacial Research
    Application Receipt/Submission Date(s): New applications - June 6, and October 4 of 2018; February 6, June 6 and October 8 of 2019; February 6, June 8, and October 6 of 2020 by 5:00 PM local time of applicant organization. Revised applications - July 6 and November 6 of 2018; March 6, July 8 and November 6 of 2019; and March 6, July 7, and November 6 of 2020), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. 
  • Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54 Clinical Trial Optional)
    (PAR-18-657)
    National Institute of Neurological Disorders and Stroke
    National Eye Institute
    National Institute of Arthritis and Musculoskeletal and Skin Diseases
    National Institute on Drug Abuse
    National Institute of Environmental Health Sciences
    Application Receipt/Submission Date(s): September 11, 2018; September 10, 2019; September 9, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. 
  • Mechanisms of Alcohol Tolerance (R21/R33 Clinical Trial Not Allowed)
    (PAR-18-659)
    National Institute on Alcohol Abuse and Alcoholism
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. 
  • Pathway and Target Identification for Alzhiemers Disease Related Dementias (ADRDs) (U01 Clinical Trial Not Allowed)
    (PAR-18-661)
    National Institute of Neurological Disorders and Stroke
    National Institute on Aging
    Application Receipt/Submission Date(s): April 16, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 
  • Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative UG3/UH3 Clinical Trial Required)
    (PAR-18-662)
    National Center for Complementary and Integrative Health
    Application Receipt/Submission Date(s): New Applications: June 1, 2018; October 3, 2018; May 31, 2019; and January 31, 2020 Resubmission Applications: June 15, 2018; October 17, 2018; June 14, 2019; and February 14, 2020 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 
  • Mind and Body Intervention Multi-Site Clinical Trial Data Coordinating Center (Collaborative U24 - Clinical Trial Required)
    (PAR-18-663)
    National Center for Complementary and Integrative Health
    Application Receipt/Submission Date(s): New Dates: June 1, 2018; October 3, 2018; May 31, 2019; and January 31, 2020 Resubmission and Revision Applications: June 15, 2018; October 17, 2018; June 14, 2019; and February 14, 2020 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 
  • Clinical Validation of Candidate Biomarkers for Neurological Diseases (U01 Clinical Trial Optional)
    (PAR-18-664)
    National Institute of Neurological Disorders and Stroke
    Application Receipt/Submission Date(s): April 17, 2018; July 18, 2018; February, 14, 2019; July 18, 2019; February 14, 2020; and July 20, 2020 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 
  • NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Clinical Trials and Clinical Research (R44 Clinical Trial Optional)
    (PAR-18-665)
    National Institute of Neurological Disorders and Stroke
    Application Receipt/Submission Date(s): April 16th then Standard dates apply , by 5:00 PM local time of applicant organization. 

Notices

  • Broad Agency Announcement: Vaccine Adjuvant Discovery Program NIAID-DAIT-NIHAI201700100
    (NOT-AI-18-018)
    National Institute of Allergy and Infectious Diseases
  • Broad Agency Announcement: Immune Mechanisms of Protection Against Mycobacterium tuberculosis Center (IMPAc-TB) NIAID-DAIT-NIHAI201700104
    (NOT-AI-18-019)
    National Institute of Allergy and Infectious Diseases
  • Notice of Intent to Publish a Funding Opportunity Announcement for Impact of Initial Influenza Exposure on Immunity in Infants (U01 Clinical Trial Not Allowed)
    (NOT-AI-18-020)
    National Institute of Allergy and Infectious Diseases
  • Notice of Interest in Advancing Research about the Effects of Opioids and Opioid Antagonists on the Fetal and Neonatal Brain Development
    (NOT-DA-17-067)
    National Institute on Drug Abuse
    Eunice Kennedy ShriverNational Institute of Child Health and Human Development 
  • Notice of NIDA Participation in PA-18-653 "Developmentally Tailored HIV Prevention and Care Research for Adolescents and Young Adults (R34 Clinical Trial Optional)"
    (NOT-DA-18-005)
    National Institute on Drug Abuse
  • Notice of Corrected Application Date PAR-18-221, " Fast-Track Development of Medications to Treat Cannabis Use Disorders UG3/UH3"
    (NOT-DA-18-006)
    National Institute on Drug Abuse
  • Request for Proposals (RFP) Notice: Synthesis and Distribution of Drugs of Abuse and Related Compounds
    (NOT-DA-18-061)
    National Institute on Drug Abuse
  • Extending Deadline for RFA-FD-18-004
    (NOT-FD-18-005)
    Food and Drug Administration
  • Notice of NIGMS Participation in PA-18-658 "Administrative Supplement for Research on Sex/Gender Influences (Admin Supp - Clinical Trial Optional)"
    (NOT-GM-18-017)
    National Institute of General Medical Sciences
  • Request for Information (RFI): Research Specific to Pregnant Women and Lactating Women (PRGLAC)
    (NOT-HD-18-003)
    Eunice Kennedy ShriverNational Institute of Child Health and Human Development 
  • Notice of NICHD Participation in PAR-18-411 "Getting To Zero: Understanding HIV Viral Suppression and Transmission in the United States (R01 Clinical Trial Not Allowed) "
    (NOT-HD-18-004)
    Eunice Kennedy ShriverNational Institute of Child Health and Human Development 
  • Notice of Intent to Publish a Funding Opportunity Announcement for Cardiothoracic Surgical Trials Network Renewal - CCC (U10 - Clinical Trials Required)
    (NOT-HL-18-588)
    National Heart, Lung, and Blood Institute
  • Notice of Correction to Application Instructions in RFA-HL-19-007: Limited Competition: Data Analysis and Coordination Center for the MACS/WIHS Combined Cohort Study (MACS/WIHS-CCS) (U01 Clinical Trial Not Allowed)
    (NOT-HL-18-591)
    National Heart, Lung, and Blood Institute
    National Cancer Institute
    National Human Genome Research Institute
    National Heart, Lung, and Blood Institute
    National Institute on Aging
    National Institute of Allergy and Infectious Diseases
    Eunice Kennedy ShriverNational Institute of Child Health and Human Development 
    National Institute on Drug Abuse
    National Institute of Dental and Craniofacial Research
    National Institute of Mental Health
    National Institute on Minority Health and Health Disparities 
    National Institute of Neurological Disorders and Stroke
    National Institute of Nursing Research
  • Notice of Correction to Application Instructions in RFA-HL-19-008: Limited Competition: Clinical Research Sites for the MACS/WIHS Combined Cohort Study (MACS/WIHS-CCS) (U01 Clinical Trial Not Allowed)
    (NOT-HL-18-592)
    National Heart, Lung, and Blood Institute
    National Cancer Institute
    National Human Genome Research Institute
    National Heart, Lung, and Blood Institute
    National Institute on Aging
    National Institute of Allergy and Infectious Diseases
    Eunice Kennedy ShriverNational Institute of Child Health and Human Development 
    National Institute on Drug Abuse
    National Institute of Dental and Craniofacial Research
    National Institute of Mental Health
    National Institute on Minority Health and Health Disparities 
    National Institute of Neurological Disorders and Stroke
    National Institute of Nursing Research
  • Notice of NIMH's Participation to PA-18-658, "Administrative Supplement for Research on Sex/Gender Influences (Admin Supp Clinical Trial Optional)
    (NOT-MH-18-022)
    National Institute of Mental Health
  • Notice of NINR involvement in RFA-TW-17-001 Health-Professional Education Partnership Initiative (HEPI) (R25 - Clinical Trial Not Allowed)
    (NOT-NR-18-008)
    National Institute of Nursing Research
  • Notice of National Institute of Neurological Disorders and Stroke (NINDS) Interest in Biomarkers Directed at Pain or Pain Therapies
    (NOT-NS-18-043)
    National Institute of Neurological Disorders and Stroke